Teleflex Incorporated (TFX)
NYSE: TFX · Real-Time Price · USD
117.53
0.00 (0.00%)
Jun 17, 2025, 4:00 PM - Market closed
Teleflex Revenue
Teleflex had revenue of $700.67M in the quarter ending March 30, 2025, a decrease of -5.04%. This brings the company's revenue in the last twelve months to $3.01B, up 0.29% year-over-year. In the year 2024, Teleflex had annual revenue of $3.05B with 2.45% growth.
Revenue (ttm)
$3.01B
Revenue Growth
+0.29%
P/S Ratio
1.82
Revenue / Employee
$213,485
Employees
14,100
Market Cap
5.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.05B | 72.84M | 2.45% |
| Dec 31, 2023 | 2.97B | 183.45M | 6.57% |
| Dec 31, 2022 | 2.79B | -18.52M | -0.66% |
| Dec 31, 2021 | 2.81B | 272.41M | 10.74% |
| Dec 31, 2020 | 2.54B | -58.21M | -2.24% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
TFX News
- 6 days ago - New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients - GlobeNewsWire
- 7 days ago - Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men's Health Month - GlobeNewsWire
- 4 weeks ago - Teleflex Publishes 2024 Global Impact Report - GlobeNewsWire
- 4 weeks ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 4 weeks ago - Teleflex Showcases New Clinical Data Presented at the 2025 American Urological Association (AUA) Annual Meeting - GlobeNewsWire
- 4 weeks ago - Teleflex Incorporated (TFX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 5 weeks ago - Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporated (TFX) Shareholders to Inquire about Securities Investigation - Accesswire
- 5 weeks ago - New Retrospective Study Reports Significantly Reduced Post-Operative GERD Rates with the Titan SGS™ Stapler from Teleflex Compared with Multi-Fire Staplers in Sleeve Gastrectomy - GlobeNewsWire